covid 19 News and Research

RSS

Statins improve 28-day mortality in hospitalized COVID-19 patients

Now, researchers at Harvard Medical School showed that statin use reduced 28-day mortality in patients hospitalized with COVID-19. Both the new initiation of statins and continuing statin therapy reduced the risk of mortality.

8 Apr 2021

High SARS-CoV-2 attack rates linked to singing events

Now, a team of researchers from the Netherlands and Sweden demonstrates that airborne spread via infectious droplets or aerosols over longer distances of more than 1.5 meters due to singing is possible during singing events.

8 Apr 2021

More new SARS-CoV-2 variants are highly likely

In a recent report posted to the bioRxiv preprint server, researchers from the United Kingdom and Uganda reveal unique protein features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to other representatives of Sarbecoviruses.

8 Apr 2021

Purdue researchers use malaria expertise to track COVID-19 in Indiana

Scientists have been using genetics to track diseases for decades. Now, a team at Purdue University that typically tracks malaria spread in Southern and Central Africa is using its expertise to track COVID-19 in Indiana.

8 Apr 2021

Moderate cycling during dialysis could improve the heart health of patients with kidney failure

Cycling at moderate intensity during dialysis could drastically improve the heart health of patients with kidney failure and result in significant savings for the NHS, according to new research by the University of Leicester supported by the charity Kidney Research UK and National Institute for Health Research Leicester Biomedical Research Centre.

8 Apr 2021

Hispanic immigrants of working age more likely to die of COVID-19 than non-Hispanics

Hispanic immigrants of working age -- 20 to 54 years old -- are over 11 times more likely to die of COVID-19 than U.S.-born men and women who are not Hispanic, according to a USC study of California death certificate data from 2020.

8 Apr 2021

Study finds more children infected by coronavirus during the second wave in Germany

A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.

8 Apr 2021

Autoantibodies may contribute to severe COVID-19 and potential long-COVID-19 symptoms

New research in the USA and China. investigated how autoantibodies could mediate NETs during a COVID-19 infection. Extensive damage to the body from neutrophil extracellular traps (NETs) after infection may be contributing to thromboinflammation and the symptoms experienced by COVID-19 ‘long-haulers’.

8 Apr 2021

Moderna COVID-19 vaccine ensures long-term protection against SARS-CoV-2 infection, suggests study

A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.

8 Apr 2021

‘Go ahead and vote me out’: What other places can learn from Santa Rosa’s tent city

It was early May, and officials in this Northern California city known for its farm-to-table dining culture and pumped-up housing prices were frantically debating how to keep covid-19 from infiltrating the homeless camps proliferating in the region's celebrated parks and trails.

8 Apr 2021

Increasing compliance with existing restrictions can stop the spread of COVID-19 virus, says expert

Responses from 9 500 inhabitants in 11 countries in a study financed by the EU have given the researchers an insight into how governments should act to stop the spread of the virus.

8 Apr 2021

Thermo Fisher Scientific launches in-air SARS-CoV-2 surveillance solution

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 8 Apr 2021

Prefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trial

A new preprint research paper posted to the medRxiv server reports the results of the first human trial of the prefusion stabilized SARS-CoV-2 spike vaccine MVC-COV1901 in Taiwan.

8 Apr 2021

Better masks, adequate ventilation can reduce spread of COVID-19 virus in enclosed spaces

With research increasingly showing the COVID-19 virus is transmissible via smaller droplets suspended in air, there is a growing concern current public health guidelines of mask wearing and social distancing are insufficient in combating its spread in indoor environments, like prisons, hospitals, and meatpacking plants, where people tend to be in close quarters.

8 Apr 2021

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

The COVID-19 vaccines currently rolling out are providing hope that the spread of the disease can be halted. But infection rates are still high, and for those who contract COVID-19, the search for effective treatments remains important.

8 Apr 2021

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

The gut is a well-established route of infection and target for viral damage by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal (GI) symptoms.

8 Apr 2021

Smartphone mobility tracking strongly predicts COVID-19 outbreaks

Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal)

8 Apr 2021

Study: 1 in 10 people still has moderate to severe symptoms after mild COVID-19

Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are a loss of smell and taste and fatigue.

8 Apr 2021

Inhibition of NLRP3 complex can reduce inflammation in melanoma patients

Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center.

8 Apr 2021

Cross-border asthma study investigates hygiene hypothesis amid COVID-19 pandemic

A cross-border investigation of children's susceptibility to asthma and other childhood illnesses in the United States and Mexico is the focus of a new study led by researchers in the Asthma and Airway Disease Research Center at the University of Arizona Health Sciences.

8 Apr 2021

covid 19 News and Research

Statins improve 28-day mortality in hospitalized COVID-19 patients

High SARS-CoV-2 attack rates linked to singing events

More new SARS-CoV-2 variants are highly likely

Purdue researchers use malaria expertise to track COVID-19 in Indiana

Moderate cycling during dialysis could improve the heart health of patients with kidney failure

Hispanic immigrants of working age more likely to die of COVID-19 than non-Hispanics

Study finds more children infected by coronavirus during the second wave in Germany

Autoantibodies may contribute to severe COVID-19 and potential long-COVID-19 symptoms

Moderna COVID-19 vaccine ensures long-term protection against SARS-CoV-2 infection, suggests study

‘Go ahead and vote me out’: What other places can learn from Santa Rosa’s tent city

Increasing compliance with existing restrictions can stop the spread of COVID-19 virus, says expert

Thermo Fisher Scientific launches in-air SARS-CoV-2 surveillance solution

Prefusion SARS-CoV-2 spike-based vaccine candidate shows high safety and efficacy in phase I trial

Better masks, adequate ventilation can reduce spread of COVID-19 virus in enclosed spaces

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

Smartphone mobility tracking strongly predicts COVID-19 outbreaks

Study: 1 in 10 people still has moderate to severe symptoms after mild COVID-19

Inhibition of NLRP3 complex can reduce inflammation in melanoma patients

Cross-border asthma study investigates hygiene hypothesis amid COVID-19 pandemic

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News